Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 3 (2007), Issue 7 (July)

1. A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer.
   J Thorac Oncol, 2(7): S115-7. [Abstract] [Full-text]
2. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.
   J Clin Oncol, 25(19): 2792-7. [Abstract] [Full-text]
3. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
   J Clin Oncol, 25(19): 2804-10. [Abstract] [Full-text]
4. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
   Pediatrics, 120(1): e47-51. [Abstract] [Full-text]
5. Pattern and outcome of admission to a medical oncology inpatient service.
   J Cancer Educ, 22(2): 80-5. [Abstract] [Full-text]
6. Adolescent and young adult (AYA) oncology: the first A.
   Pediatr Hematol Oncol, 24(5): 325-36. [Abstract] [Full-text]
7. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
   Lancet Oncol, 8(7): 613-24. [Abstract] [Full-text]
8. Brief report: psychosocial functioning of fathers as primary caregivers of pediatric oncology patients.
   J Pediatr Psychol, 32(7): 851-6. [Abstract] [Full-text]
9. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
   Clin J Oncol Nurs, 11(3): 361-76. [Abstract] [Full-text]
10. Knowledge and attitudes about cancer pain management: A national survey of Italian oncology nurses.
    Eur J Oncol Nurs, 11(3): 272-9. [Abstract] [Full-text]
11. Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI Rodriguez O, Fricke S, Chien C, Dettin L, VanMeter J, Shapiro E, Dai HN, Casimiro M, Ileva L, Dagata J, Johnson MD, Lisanti MP, Koretsky A, Albanese C, Lombardi Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC.
    Urol Oncol, 25(4): 357-8. [Abstract] [Full-text]
12. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
    Urol Oncol, 25(4): 338-40. [Abstract] [Full-text]
13. Evidence based radiation oncology: Breast cancer.
    Radiother Oncol, 84(1): 84-101. [Abstract] [Full-text]
14. The impact of oncology education on practice-A literature review.
    Eur J Oncol Nurs, 11(3): 255-61. [Abstract] [Full-text]
15. Citalopram to treat depression in pediatric oncology.
    J Child Adolesc Psychopharmacol, 17(3): 371-7. [Abstract] [Full-text]
16. Surgical and oncology trials for rectal cancer: who will participate?
    Surgery, 142(1): 94-101. [Abstract] [Full-text]
17. Predictive oncology: A review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth.
    Neuroimage. [Abstract] [Full-text]
18. Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
    Pediatr Blood Cancer, 49(3): 250-5. [Abstract] [Full-text]
19. Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.
    Pediatr Blood Cancer, 49(3): 352-7. [Abstract] [Full-text]
20. Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211).
    Int J Gynecol Cancer, 17(4): 784-8. [Abstract] [Full-text]
21. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
    Int J Radiat Oncol Biol Phys, 68(4): 1145-50. [Abstract] [Full-text]
22. Outline for Writing an Article for Current Treatment Options in Oncology: Splenic Lymphoma with Villous Lymphocytes.
    Curr Treat Options Oncol. [Abstract] [Full-text]
23. Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
    J Clin Oncol, 25(21): 3082-9. [Abstract] [Full-text]
24. Metabolic and molecular imaging in neuro-oncology.
    Lancet Neurol, 6(8): 711-24. [Abstract] [Full-text]
25. Is rural radiation oncology practice quality as good as the big smoke? Results of the Australian radiotherapy single machine unit trial.
    Australas Radiol, 51(4): 381-5. [Abstract] [Full-text]
26. Standards for thoracic surgical oncology in a single-payer healthcare system.
    Ann Thorac Surg, 84(2): 693-701. [Abstract] [Full-text]
27. Prescribing patterns and purchasing costs of long-acting opioids over nine years at an academic oncology hospital.
    Am J Health Syst Pharm, 64(15): 1619-25. [Abstract] [Full-text]
28. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
    Gynecol Oncol, 106(2): 325-33. [Abstract] [Full-text]
29. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
    Gynecol Oncol, 106(2): 362-9. [Abstract] [Full-text]
30. Preparing for the future of radiation oncology.
    J Am Coll Radiol, 4(8): 560-2. [Abstract] [Full-text]
31. Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report.
    Br J Haematol, 138(4): 506-12. [Abstract] [Full-text]
32. Molecularly targeted oncology therapeutics and prolongation of the QT interval.
    J Clin Oncol, 25(22): 3362-71. [Abstract] [Full-text]
33. Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group.
    J Clin Oncol, 25(22): 3296-301. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.